1b:I[201383,["/_next/static/chunks/0-2fkyrvv366g.js","/_next/static/chunks/0uqi.4-~sxoxp.js","/_next/static/chunks/11699jp.ad9_u.js","/_next/static/chunks/126iszi3alvof.js","/_next/static/chunks/0d5-uth9opvvk.js","/_next/static/chunks/02sv~84j3d._7.js","/_next/static/chunks/05.-unydf3vxz.js","/_next/static/chunks/0hqf4mpkr77_6.js","/_next/static/chunks/0alt3m~mz5lhy.js","/_next/static/chunks/0i.l9589uvx0j.js","/_next/static/chunks/17c767_95-1-~.js","/_next/static/chunks/0r5fd_3r10iu8.js","/_next/static/chunks/0vu3cagu4_i-p.js","/_next/static/chunks/0.4_spcyv1w21.js","/_next/static/chunks/0gpeale3-k0lg.js","/_next/static/chunks/0kkt2iqxj.eee.js","/_next/static/chunks/0s15fsy79qigp.js","/_next/static/chunks/0c7v-ark92b4c.js","/_next/static/chunks/0ntd7k2pyndo3.js","/_next/static/chunks/0um-frkbeqxtt.js","/_next/static/chunks/11_1y6xe~0c~k.js","/_next/static/chunks/02-u6qtmsnqn0.js","/_next/static/chunks/13o6w8.-l~3qy.js","/_next/static/chunks/060sa9q2~1ke4.js","/_next/static/chunks/0hd3~ff86sj7g.js","/_next/static/chunks/0fjtf.zde3rtf.js","/_next/static/chunks/16fy~1phjj3~6.js","/_next/static/chunks/0tnnb3~ea_sg5.js","/_next/static/chunks/0nyg3_-yddm21.js","/_next/static/chunks/0z0tzykfx1~tx.js","/_next/static/chunks/0pg009f50bl1j.js","/_next/static/chunks/0cd56v3rqdd5m.js"],"default"] 1c:T4de,

This guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) clarifies the MHRA’s expectations on the control of electronic issue of blood components.

It should be used in conjunction with:

British Committee for Standards in Haematology (BCSH) guidelines for blood bank computing
BCSH guidelines for compatibility procedures in blood transfusion laboratories
Blood Safety and Quality Regulations (SI 2005 No. 50, as amended) Regulation 9 (1) b, referencing Commission Directive 2005/62/EC ‘standards and specifications relating to a quality system for blood establishments’

Electronic issue of blood components